Dr Reddys Laboratories (RDY) Shares Outstanding (Weighted Average): 2018-2025
- Dr Reddys Laboratories' Shares Outstanding (Weighted Average) rose 0.17% to $834.1 million in Q1 2025 from the same period last year, while for Mar 2025 it was $834.1 million, marking a year-over-year increase of 0.17%. This contributed to the annual value of $834.1 million for FY2025, which is 0.17% up from last year.
- Per Dr Reddys Laboratories' latest filing, its Shares Outstanding (Weighted Average) stood at $834.1 million for Q1 2025, which was up 0.17% from $832.6 million recorded in Q1 2024.
- Dr Reddys Laboratories' 5-year Shares Outstanding (Weighted Average) high stood at $834.1 million for Q1 2025, and its period low was $830.9 million during Q1 2021.
- Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $832.6 million (2024), whereas its average is $833.0 million.
- Data for Dr Reddys Laboratories' Shares Outstanding (Weighted Average) shows a peak YoY grew of 0.17% (in 2025) over the last 5 years.
- Quarterly analysis of 5 years shows Dr Reddys Laboratories' Shares Outstanding (Weighted Average) stood at $830.9 million in 2021, then rose by 0.08% to $831.5 million in 2022, then rose by 0.07% to $832.1 million in 2023, then grew by 0.06% to $832.6 million in 2024, then rose by 0.17% to $834.1 million in 2025.
- Its Shares Outstanding (Weighted Average) was $834.1 million in Q1 2025, compared to $832.6 million in Q1 2024 and $832.1 million in Q1 2023.
